Invention Grant
- Patent Title: Heterocyclic amides as kinase inhibitors
-
Application No.: US16299254Application Date: 2019-03-12
-
Publication No.: US10933070B2Publication Date: 2021-03-02
- Inventor: Jae U. Jeong , Deepak Bandyopadhyay , Patrick M. Eidam , Philip Anthony Harris , Jianxing Kang , Bryan Wayne King , Ami Lakdawala Shah , Lara Kathryn Leister , Attiq Rahman , Joshi M. Ramanjulu , Clark A. Sehon , Robert Singhaus, Jr. , Daohua Zhang
- Applicant: GlaxoSmithKline Intellectual Property Development Limited
- Applicant Address: GB Middlesex
- Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee Address: GB Middlesex
- Agent Nora L. Stein; Fang Qian; Kathryn Lutomski
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61K31/551 ; A61K31/553 ; C07D413/14 ; C07D403/14 ; C07D409/12 ; C07D413/12 ; C07D417/12 ; C07D487/04 ; C07D267/14 ; C07D498/04 ; C07D281/10 ; C07D403/12 ; C07D223/08
Abstract:
Disclosed are compounds having the formula: wherein X, Y, Z1, Z2, Z3, Z4, R5, RA, m, A. L, and B are as defined herein, and methods of making and using the same.
Public/Granted literature
- US20190201413A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS Public/Granted day:2019-07-04
Information query
